Join to View Full Profile
4501 X StSuite 3016Sacramento, CA 95817
Phone+1 916-734-3772
Fax+1 916-734-7946
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Cheryl Ho, MD is an oncologist in Sacramento, California.
Clinical Trials
- Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC Start of enrollment: 2019 Mar 19
- Study of CTDNA Response Adaptive Immuno-Chemotherapy in NSCLC Start of enrollment: 2020 May 26
Publications & Presentations
PubMed
- Treating anaplastic lymphoma kinase (ALK) fusion-driven metastatic non-small cell lung cancer (NSCLC) with alectinib through pregnancy.Florence Wu, Rebekah Rittberg, Kenneth Lim, Cheryl Ho
BMJ Case Reports. 2024-03-25 - 1 citationsHyper-Sensitive? Targeted Therapy With a Primed Immune System.Rebekah Rittberg, Ninan Abraham, Janessa Laskin, Cheryl Ho
Journal of Thoracic Oncology. 2022-06-01 - Increasing Transparency in Author Contributions to Manuscripts: Enhanced Policy on Ghost and Honorary Authorships.Alex A. Adjei, Sai-Hong Ignatius Ou, Cheryl Ho, Jean-Louis Pujol, Sumithra J. Mandrekar
Journal of Thoracic Oncology. 2021-05-01
Press Mentions
UBC, BC Cancer Researchers Develop AI Model to Predict Cancer Survival RatesMarch 27th, 2023- How the Pandemic Has Hurt the Health of People Experiencing HomelessnessSeptember 29th, 2021
- Roche Canada Announces Collaboration to Improve Access to Personalized Healthcare with Real World EvidenceMay 28th, 2021
- Join now to see all
